⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
PDE4 Inhibitors (Roflumilast / Rolipram)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-08 — Phosphodiesterase 4 inhibitors extend lifespan of C. elegans and attenuate cellular senescence of mouse embryonic fibroblasts.: C. elegans lifespan extension by roflumilast and rolipram plus attenuated passage-induced senescence in mouse embryonic fibroblasts, attributed to PKA-driven mitochondrial improvement and reduced oxidative stress (animal/preclinical, no mammalian lifespan or human outcome data). [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Phosphodiesterase 4 inhibitors extend lifespan of C. elegans and attenuate cellular senescence of mouse embryonic fibroblasts.
08-oct-2026
novelty 3
per-area 3
strengthens